ArticleJournal of clinical laboratory analysis2026
Phenotypic and Molecular Characterization of Naganishia uzbekistanensis: Diagnostic Challenges and Antifungal Resistance Profile.
Article in Journal of clinical laboratory analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundNaganishia (N.) uzbekistanensis is a rare basidiomycetous yeast within the family Filobasidiaceae, widely distributed in environmental niches, with very limited clinical data available. Its clinical and microbiological features remain poorly understood, posing diagnostic challenges in clinical microbiology laboratories.
methodsWe describe a pulmonary infection caused by N. uzbekistanensis strain CY11558 and present an expanded laboratory investigation of this previously reported clinical strain. The strain was analyzed using a comprehensive laboratory workflow that included conventional culture, light microscopy, scanning electron microscopy (SEM), and molecular identification based on rDNA sequencing. Phylogenetic analysis was conducted to assess the genetic relationship with reference strains. Antifungal susceptibility testing and in vitro Titan cell induction assays were also performed.
resultsConventional MALDI-TOF MS failed to identify the strain, while rDNA sequencing confirmed N. uzbekistanensis. Cryptococcal antigen testing yielded a weakly positive result with the pure culture supernatant, while the patient's serum remained negative. The strain showed markedly elevated MICs for echinocandins, flucytosine, and fluconazole, whereas MICs for voriconazole, itraconazole, and amphotericin B were comparatively low. Microscopic examination revealed round yeast cells without pseudohyphae. SEM showed globular cells enveloped by a fibrillar network. Titan cell formation was not observed. Phylogenetic analysis demonstrated intraspecies variability without geographic association.
conclusionsThis study provides comprehensive phenotypic, including antifungal susceptibility, and molecular characterization of N. uzbekistanensis, emphasizing the need for molecular tools in identifying uncommon yeasts. The findings expand current understanding of its morphological and resistance traits and highlight potential diagnostic challenges in clinical laboratories.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.